Dr. Brent Jacob Geffen, MD

Dr. Geffen practices at West Coast Ear Nose and Throat in Simi Valley, California.

Dr. Geffen's NPI, 1528562527, was assigned on March 22, 2018. Dr. Geffen graduated from Wake Forest School of Medicine in 2018. Dr. Geffen holds California license 185833.

Dr. Geffen's primary practice is West Coast Ear Nose and Throat, at 2876 Sycamore Dr, Simi Valley, CA 93065 in Ventura County. The practice phone is (805) 527-7320.

Dr. Geffen's primary practice is West Coast Ear Nose and Throat in Simi Valley, California. Dr. Geffen is also affiliated with Los Robles Regional Medical Center. The medical group on file is BASS Medical Group. Dmand AI also links Dr. Geffen to 1 more hospital, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Geffen practices, 4 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Geffen's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dmand AI has Dr. Geffen's licenses on file in 2 states: California and Utah.

Dmand AI lists chronic nasal allergies, ear eustachian tube disorders, ear infection, hearing loss and impairment, larynx and vocal cord disease, swimmer's ear, tinnitus and vertigo among the conditions Dr. Geffen treats.

CMS data shows 1,656 Medicare services from Dr. Geffen across 13 procedure codes in 2024, for 721 Medicare patients. Medicare paid $130,530 for them. Every service was in an office.

CMS counts 721 Medicare patients who saw Dr. Geffen in 2024. The largest group is 65 to 74, with 296 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 12% are also on Medicaid. Their average risk score is 1.23, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Geffen's median patient age at 53, with 53% women.

In 2024, Dr. Geffen wrote 583 Medicare Part D claims for 270 patients. 97% of them were for generic drugs. CMS names the drug for 471 of them, across 15 drugs with 11 or more claims each, at $8,639 in total drug cost. In 2023, CMS named 87 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Dr. Geffen for performance year 2024, reported as part of a group. Dr. Geffen accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 1 paper to Dr. Geffen in 2022. Dr. Geffen's most frequent co-authors are Albert H. Park, MD and Dennis S. Poe, MD.

CMS Open Payments shows 52 general payments to Dr. Geffen from 8 drug and device companies from 2022 to 2025. Food and beverage make up the largest share, 50% of the total. Inspire Medical Systems, Inc. paid the most, $2,100.

Dr. Geffen graduated from Wake Forest School of Medicine in 2018. Dr. Geffen is a member of ACS.

Dr. Geffen is in network with 9 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.